GoingToMeet

China is actively building its fundamental medical infrastructure by aggressively investing in the healthcare industry, which will promote the wellbeing of 1.3 billion people. Pioneering medical device manufacturers are contributing to this historic process by manufacturing and introducing sound patient-care products to China’s market. However, guaranteeing that the products hit the market in time, poses great challenges for the newcomers as well as for those already established in China. In the meantime, the State Food and Drug Administration is enforcing stringent regulations and acting to strengthen the registration and safety surveillance of the devices. Consequently, vital questions are being raised such as: how can the registration procedure be accelerated, how should a successful and responsible trial be conducted and how are the SFDA’s safety requirements monitored?

Despite the challenges, China’s market is extremely promising and the real question is, “How Will You Capitalize On the Opportunities In China’s Medical Device Industry?”

With eminent speakers from regulatory departments, investment companies, hospitals of Grade III Level A, leading manufacturers and other industry stakeholders, Noppen presents the most informative and influential gathering for the medical device industry.